Breakthrough zygomycoses in patients receiving antifungal therapy with voriconazole.

被引：0
|
作者：
Balasubramanian, L [1 ]
Trifilio, SM [1 ]
Tallman, M [1 ]
Mehta, J [1 ]
Bennett, C [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：601S / 601S
页数：1
相关论文
共 50 条
  • [31] Breakthrough Psoriasis in Patients Receiving Biologicals
    Damsin, Thomas
    Absil, Gilles
    Libon, Florence
    Tassoudji, Nazli
    Nikkels, Arjen F.
    PSORIASIS-TARGETS AND THERAPY, 2025, 15 : 1 - 8
  • [32] Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy
    Li, Hao
    Li, Mo
    Yan, Jinqi
    Gao, Lan
    Zhou, Linjing
    Wang, Yang
    Li, Qi
    Wang, Jin
    Chen, Tianjun
    Wang, Taotao
    Zheng, Jie
    Qiang, Wei
    Zhang, Yongjian
    Shi, Qindong
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 (06) : 495 - 504
  • [33] Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
    Vazquez, Lourdes
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2016, 29 : 3 - 5
  • [34] The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole
    Barreto, Jason N.
    Beach, Cassidy L.
    Wolf, Robert C.
    Merten, Julianna A.
    Tosh, Pritish K.
    Wilson, John W.
    Hogan, William J.
    Litzow, Mark R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (04) : 283 - 288
  • [35] Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review
    Boutin, Catherine-Audrey
    Durocher, Florence
    Beauchemin, Stephanie
    Ziegler, Daniela
    Abou Chakra, Claire Nour
    Dufresne, Simon Frederic
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (01) : 151 - 160
  • [36] The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis
    Chris Kosmidis
    Anna Mackenzie
    Chris Harris
    Rola Hashad
    Fiona Lynch
    David W. Denning
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2020, 393 : 2233 - 2237
  • [37] The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis
    Kosmidis, Chris
    Mackenzie, Anna
    Harris, Chris
    Hashad, Rola
    Lynch, Fiona
    Denning, David W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (11) : 2233 - 2237
  • [38] Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD
    Gergis, U.
    Markey, K.
    Greene, J.
    Kharfan-Dabaja, M.
    Field, T.
    Wetzstein, G.
    Schell, M. J.
    Huang, Y.
    Anasetti, C.
    Perkins, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 (04) : 662 - 667
  • [39] Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD
    U Gergis
    K Markey
    J Greene
    M Kharfan-Dabaja
    T Field
    G Wetzstein
    M J Schell
    Y Huang
    C Anasetti
    J Perkins
    Bone Marrow Transplantation, 2010, 45 : 662 - 667
  • [40] Virologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy
    Ismail, Sohair
    Hafez, Hanan Abdel
    Darweesh, Samar K.
    Kamal, Kamal Hassan
    Esmat, Gamal
    ANNALS OF GASTROENTEROLOGY, 2014, 27 (04): : 380 - 386
12345